A detailed history of Mairs & Power Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Mairs & Power Inc holds 43,710 shares of EXAS stock, worth $2.17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
43,710
Previous 38,525 13.46%
Holding current value
$2.17 Million
Previous $1.63 Million 82.91%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $219,999 - $367,253
5,185 Added 13.46%
43,710 $2.98 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $604,244 - $1.09 Million
14,620 Added 61.16%
38,525 $1.63 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $5,908 - $7,745
105 Added 0.44%
23,905 $1.65 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $722,330 - $1.26 Million
23,800 New
23,800 $1.18 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.